Project Number 5R01AG046179-04 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for DOMINANTLY INHERITED ALZHEIMER'S NETWORK TRIALS UNIT - ADAPTIVE PREVENTION TRIAL Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator Bateman, Randall Principal Investigator First Name Randall Principal Investigator Last Name Bateman Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-015: ALZHEIMER'S DISEASE PREVENTION TRIALS (R01) FY Overall Cost $5,232,087 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MCLINDEN, KRISTINA Related Resources Clinical Trial Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
